Contrasting Alpha Tau Medical (NASDAQ:DRTS) and Autonomix Medical (NASDAQ:AMIX)

Autonomix Medical (NASDAQ:AMIX) and Alpha Tau Medical (NASDAQ:DRTS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, profitability, earnings, dividends, analyst recommendations and institutional ownership.

Risk and Volatility

Autonomix Medical has a beta of -2.48, meaning that its share price is 348% less volatile than the S&P 500. Comparatively, Alpha Tau Medical has a beta of 1.04, meaning that its share price is 4% more volatile than the S&P 500.

Valuation & Earnings

This table compares Autonomix Medical and Alpha Tau Medical”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Autonomix Medical	N/A	N/A	-$11.41 million	($3.55)	-0.10
Alpha Tau Medical	N/A	N/A	-$42.63 million	($0.53)	-14.92

Alpha Tau Medical is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Autonomix Medical and Alpha Tau Medical, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	1	1	1	0	2.00
Alpha Tau Medical	1	2	2	0	2.20

Autonomix Medical presently has a consensus target price of $2.00, indicating a potential upside of 454.02%. Alpha Tau Medical has a consensus target price of $8.67, indicating a potential upside of 9.57%. Given Autonomix Medical’s higher possible upside, analysts plainly believe Autonomix Medical is more favorable than Alpha Tau Medical.

Profitability

This table compares Autonomix Medical and Alpha Tau Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-228.82%	-186.65%
Alpha Tau Medical	N/A	-57.29%	-42.39%

Insider & Institutional Ownership

10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are owned by institutional investors. 6.2% of Autonomix Medical shares are owned by company insiders. Comparatively, 39.5% of Alpha Tau Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Alpha Tau Medical beats Autonomix Medical on 7 of the 11 factors compared between the two stocks.

About Autonomix Medical

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

About Alpha Tau Medical

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.